Reference Medicinal Product (RMP)/ Innovator/ Originator

Categories:

Definition

An existing medicine that is regulatory approved and available on the market. Biosimilars are developed to be highly similar to an originator drug.

Related Content & Resources

Knowledge Center

On-Demand Webinar: Effective Biosimilar Comparability Studies WATCH NOW
Biosimilar Testing: Structural and Physico-Chemical Comparability Analysis Read More

Case Study

Indian Biosimilar Company- Biosimilar Comparability Study

Our client required structural and physicochemical comparability data for a number of innovator and biosimilar molecules in order to provide comparability data for key quality attributes and demonstrate biocomparability.